Biotech Top Losers: Xencor (NASDAQ:XNCR), Flex Pharma (NASDAQ:FLKS), Minerva Neurosciences (NASDAQ:NERV), Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), Xenon Pharmaceuticals Inc. (NASDAQ:XENE)
Xencor, Inc. (NASDAQ:XNCR), reported top-line interim results from a Phase 1a study for XmAb®7195. The data show rapid reduction of circulating free IgE levels to below the limit of detection in 90% of XmAb7195 treated subjects that had detectable freeRead More